Regulatory T cell therapy in solid organ transplantation: clinical applications and laboratory monitoring strategies

Regulatory T cells (Tregs) play a fundamental role in maintaining immunological homeostasis and sustaining immune tolerance. In solid organ transplantation, Tregs have emerged as a promising strategy of cellular immunotherapy capable of reducing allograft rejection and mitigating long-term complications. Early-phase clinical studies have established the safety and feasibility of adoptive Treg therapy. Building on these pivotal findings, Treg therapy has created a solid foundation for translational application. However, successful clinical implementation requires a deeper understanding of Treg biology, clarification of their mechanisms of action, and the development of reliable strategies for in vivo monitoring. This review provides a detailed overview of Treg mechanisms, ongoing clinical trials, and methodological approaches for evaluating their phenotype and function through cell-based, protein-based, and gene-based assays. In addition, it highlights key considerations for optimizing therapeutic efficacy and ensuring safety, with the ultimate aim of advancing Treg therapy toward routine clinical use in solid organ transplantation.

• Publication year

  2025

• Venue

  Clinical transplantation and research

• Publication date

  2025-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.4285/ctr.25.0040PMID 40936404PMCID 12521849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function.

  2025cited by this paper
• Complications Associated with Immunosuppressive Agents in Solid Organ Transplant Recipients: A Nationwide Analysis

  2025cited by this paper
• Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?

  2024cited by this paper
• Single-Cell RNA Sequencing in Organ and Cell Transplantation

  2024cited by this paper
• Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials

  2024cited by this paper
• Mini-review of DNA Methylation Detection Techniques and Their Potential Applications in Disease Diagnosis, Prognosis, and Treatment.

  2024cited by this paper
• Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class II.

  2024cited by this paper
• Simultaneous Epigenetic and Gene Expression Profiling at Single Cell Resolution Uncovers Stem-Like Treg Subsets Induced With Oligonucleotide Expansion in Humans

  2024cited by this paper
• Single cell RNA-sequencing delineates CD8+ tissue resident memory T cells maintaining rejection in liver transplantation

  2024cited by this paper
• Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma

  2023cited by this paper
• Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

  2023cited by this paper
• Tregs in transplantation tolerance: role and therapeutic potential

  2023cited by this paper
• Treg therapy: the price of specificity.

  2023cited by this paper
• PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis

  2023cited by this paper
• Modulation of T cells by tryptophan metabolites in the kynurenine pathway.

  2023cited by this paper
• Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial.

  2023cited by this paper
• Eras of designer Tregs: Harnessing synthetic biology for immune suppression

  2023cited by this paper
• Methods to Assess Proliferation of Stimulated Human Lymphocytes In Vitro: A Narrative Review

  2023cited by this paper
• Chimeric antigen receptor Treg therapy in transplantation.

  2023cited by this paper
• Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients

  2022cited by this paper
• CD4+CD25+ T regulatory cells in renal transplantation

  2022cited by this paper
• Cytolytic CD4+ and CD8+ Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease

  2022cited by this paper
• Unveiling the underpinnings of various non-conventional ELISA variants: a review article

  2022cited by this paper
• Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation

  2022cited by this paper
• Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation

  2022cited by this paper
• Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!

  2022cited by this paper
• Regulatory T Cells: Regulation of Identity and Function

  2021cited by this paper
• Phenotypic and Functional Diversity in Regulatory T Cells

  2021cited by this paper
• Coexpression of Helios in Foxp3+ Regulatory T Cells and Its Role in Human Disease

  2021cited by this paper
• Regulatory T Cells-Related Genes Are under DNA Methylation Influence

  2021cited by this paper
• Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings

  2021cited by this paper
• Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

  2021cited by this paper
• Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

  2021cited by this paper
• An accurate and rapid single step protocol for enumeration of cytokine positive T lymphocytes.

  2020cited by this paper
• Donor‐specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients

  2020cited by this paper
• New Answers to an Old Question

  2020cited by this paper
• Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.

  2020cited by this paper
• Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use

  2020cited by this paper
• The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations

  2020cited by this paper
• Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

  2020cited by this paper
• Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4+CD25+FOXP3+ Regulatory T Cells and Prolonged Human Islet Allograft Survival in Humanized Mice

  2020cited by this paper
• Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised

  2020cited by this paper
• Treg cell-based therapies: challenges and perspectives

  2019cited by this paper
• Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System

  2019cited by this paper
• Methods to manufacture regulatory T cells for cell therapy

  2019cited by this paper
• Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

  2019cited by this paper
• Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity

  2019cited by this paper
• A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

  2018cited by this paper
• Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells

  2017cited by this paper
• Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

  2017cited by this paper
• IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154–CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice

  2017cited by this paper
• Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection

  2017cited by this paper
• An essential role for IL-2 receptor in regulatory T cell function

  2016cited by this paper
• A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation

  2016influential reference
• In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation

  2016cited by this paper
• T regulatory Cell-mediated Immunotherapy for Solid Organ Transplantation: A Clinical Perspective

  2016cited by this paper
• An essential role for the IL-2 receptor in Treg cell function

  2016cited by this paper
• Analytical evaluation of a real-time PCR-based DNA demethylation assay to assess the frequency of naturally occurring regulatory T cells in peripheral blood.

  2016cited by this paper
• CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression

  2016cited by this paper
• Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

  2015cited by this paper
• Control of Regulatory T Cell Migration, Function, and Homeostasis

  2015cited by this paper
• Long-Term Toxicity of Immunosuppressive Therapy

  2015cited by this paper
• Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro

  2014cited by this paper
• Cytokine detection by flow cytometry.

  2014cited by this paper
• Evaluation of immunosuppressive function of regulatory T cells using a novel in vitro cytotoxicity assay

  2014cited by this paper
• Clinical Grade Manufacturing of Human Alloantigen‐Reactive Regulatory T Cells for Use in Transplantation

  2013influential reference
• Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses

  2012cited by this paper
• Detection and quantification of cytokines and other biomarkers.

  2012cited by this paper
• Molecular Mechanisms of Treg-Mediated T Cell Suppression

  2012cited by this paper
• Differing Effects of Rapamycin or Calcineurin Inhibitor on T‐Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients

  2012cited by this paper
• CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4+ T effector cells in patients with head and neck squamous cell carcinoma

  2012cited by this paper
• Suppression assays with human T regulatory cells: A technical guide

  2012cited by this paper
• Low‐Dose IL‐2 for In Vivo Expansion of CD4+ and CD8+ Regulatory T Cells in Nonhuman Primates

  2012cited by this paper
• Regulatory T-cell therapy for transplantation: how many cells do we need?

  2012cited by this paper
• Ligation of Cytotoxic T Lymphocyte Antigen-4 to T Cell Receptor Inhibits T Cell Activation and Directs Differentiation into Foxp3+ Regulatory T Cells*

  2012cited by this paper
• Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

  2011cited by this paper
• Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

  2011cited by this paper
• Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.

  2011cited by this paper
• Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10

  2011cited by this paper
• Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay.

  2011cited by this paper
• In vitro Treg suppression assays.

  2011cited by this paper
• Antigen-specific T-regulatory cells can extend skin graft survival time in mice.

  2011cited by this paper
• Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells

  2011cited by this paper
• Peripheral blood T Regulatory cell counts may not predict transplant rejection

  2010cited by this paper
• First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.

  2009cited by this paper
• Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1

  2009cited by this paper
• Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells*

  2009cited by this paper
• Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes

  2009cited by this paper
• Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.

  2009cited by this paper
• Mechanisms of costimulation

  2009cited by this paper
• Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

  2008cited by this paper
• Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II1

  2008cited by this paper
• Interferon-&ggr; Conditioning Ex Vivo Generates CD25+CD62L+Foxp3+ Regulatory T Cells That Prevent Allograft Rejection: Potential Avenues for Cellular Therapy

  2008cited by this paper
• FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable Outcomes

  2008cited by this paper
• Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II

  2008cited by this paper
• ELISA and multiplex technologies for cytokine measurement in inflammation and aging research.

  2008cited by this paper
• How regulatory T cells work

  2008cited by this paper
• Acquisition of Suppressive Function by Activated Human CD4+CD25− T Cells Is Associated with the Expression of CTLA-4 Not FoxP31

  2008cited by this paper
• DNA methylation controls Foxp3 gene expression

  2008cited by this paper
• Regulatory T cells and immune tolerance.

  2008cited by this paper

• No citing papers are available for this paper.